Trials / Completed
CompletedNCT01224223
Myeloid Suppressors in Inflammation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- University of South Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Myeloid-derived suppressor cells (MDSC) have been studied for their ability to suppress T cell responses in vivo and in vitro. As a result, MDSC can regulate cellular responses to chronic inflammatory conditions such as cancer, leading to the induction of tolerance and, ultimately, tumor escape from immune surveillance.
Conditions
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2010-10-19
- Last updated
- 2012-06-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01224223. Inclusion in this directory is not an endorsement.